Biodexa Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BDRX and other ETFs, options, and stocks.

About BDRX

Biodexa Pharmaceuticals Plc is a drug delivery technology company. It is focused on the research and development of medicines for rare cancers, via both in-house programs as well as partnered programs. 

CEO
Stephen Anthony Stamp
CEOStephen Anthony Stamp
Employees
11
Employees11
Headquarters
Cardiff, Cardiff
HeadquartersCardiff, Cardiff
Founded
2000
Founded2000
Employees
11
Employees11

BDRX Key Statistics

Market cap
1.44M
Market cap1.44M
Price-Earnings ratio
-0.03
Price-Earnings ratio-0.03
Dividend yield
Dividend yield
Average volume
1.94M
Average volume1.94M
High today
$3.20
High today$3.20
Low today
$3.20
Low today$3.20
Open price
$3.22
Open price$3.22
Volume
358.00
Volume358.00
52 Week high
$96.50
52 Week high$96.50
52 Week low
$2.86
52 Week low$2.86

BDRX News

TipRanks 5d
Biodexa Pharmaceuticals Proposes Major Share Capital Reorganization Ahead of June AGM

Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions Discover top-performing stock ideas and upgrade to a portfolio of mark...

Investing.com 5d
Biodexa proposes share capital reorganization at June meeting - Investing.com

...

Biodexa proposes share capital reorganization at June meeting - Investing.com

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.